Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
05/2002
05/10/2002WO2002036583A1 Pgd2 receptor antagonistic pharmaceutical compositions
05/10/2002WO2002036565A1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
05/10/2002WO2002036555A1 Sulfamides as gamma-secretase inhibitors
05/10/2002WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/10/2002WO2002018364A3 Process for preparing 2-phenyl-3-aminobenzothiophenes
05/10/2002WO2002016338A8 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
05/10/2002WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
05/10/2002CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/09/2002US20020055643 Tubulin binding ligands and corresponding prodrug constructs
05/09/2002US20020055631 N-acylsulfonamide apoptosis promoters
05/09/2002US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
05/09/2002US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/08/2002EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors
05/08/2002EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
05/08/2002EP1202968A2 Antibacterial agents
05/08/2002EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives
05/08/2002EP1202726A2 Method for treating chronic pain using mek inhibitors
05/08/2002DE10054482A1 Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them
05/08/2002CN1348459A Heterocyclic metallocene compounds and use thereof in catalyst systems for producing olefin polymers
05/08/2002CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids
05/08/2002CN1348439A New compounds, their preparation and use
05/07/2002US6384281 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors
05/07/2002US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase
05/07/2002US6384075 Treating diseases in which mast cell dysfunction is involved
05/07/2002US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
05/07/2002US6384035 Heterocycles useful in the treatment of benign prostatic hyperplasia
05/07/2002US6384033 Drugs for vision defects
05/07/2002US6383988 Thienysulfonylamino (thio) carbonyl compounds
05/02/2002WO2002034741A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE
05/02/2002WO2002034711A1 Biaryl compounds as serine protease inhibitors
05/02/2002WO2001096283A3 Hiv integrase inhibitors
05/02/2002WO2001064642A3 Benzamides and related inhibitors of factor xa
05/02/2002WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
05/02/2002WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/02/2002US20020052512 Diaminopropionic acid derivatives
05/02/2002US20020052401 Benzophenones and sulfones as inhibitors of glycine uptake
05/02/2002US20020052399 In particular as inhibitors of HIV protease.
05/02/2002US20020052378 Novel compounds and compositions as protease inhibitors
05/02/2002US20020052349 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents
05/02/2002US20020052007 Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
05/02/2002EP1201650A2 Ionic malonitril derivatives and their uses
05/02/2002EP1201648A1 Carbamate derivatives and agricultural/horticultural bactericides
05/02/2002EP1200457A2 Cysteine protease inhibitors
05/02/2002EP1200426A1 Substituted thiene-3-yl-sulfonyl amino(thio)carbonyl-triazolin(thi)ones
05/02/2002EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors
05/02/2002EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor
05/02/2002EP1200393A1 Oxime amides and hydrazone amides having fungicidal activity
05/02/2002EP1200076A1 Calcilytic compounds
05/02/2002EP0530338B1 Anisotropic organic compounds
05/02/2002DE10049484A1 Anticonvulsant, anxiolytic and especially analgesic medicaments, comprising new or known beta-thio-alpha-aminoacid compounds having strong affinity for gabapentin binding site
05/02/2002DE10049483A1 Substituierte 1-Aminobutan-3-ol-Derivate Substituted 1-aminobutan-3-ol derivatives
05/02/2002DE10049481A1 Substituierte C-Cyclohexylmethylamin-Derivate C-substituted derivatives cyclohexylmethylamine
05/02/2002CA2426430A1 Biaryl compounds as serine protease inhibitors
05/02/2002CA2426007A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
05/01/2002CN1347424A Metallocene compounds, process for their preparation and their use in catalytic systems for polymerization of olefins
05/01/2002CN1347417A 4-oxo-4,7-dihydro-thieno [2,3-b] pyridine-5-carboxamides as antiviral agent
05/01/2002CN1347406A Carbamic acid derivs. and their use as metabotropic glutamate receptor ligands
05/01/2002CN1083831C Novel tricyclic compounds and drug compositions contg. same
04/2002
04/30/2002US6380429 Oxidation of sulfonamide
04/30/2002US6380392 Complexes
04/30/2002US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
04/30/2002US6380249 HIV integrase inhibitors
04/30/2002US6380246 For combating pests and weeds
04/30/2002US6380243 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and kaposi herpesvirus.
04/30/2002US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety
04/30/2002US6380223 For therapy of diseases, such as obesity, diabetes, inflammation
04/30/2002US6380221 Ortho-anthranilamide derivatives as anti-coagulants
04/30/2002US6380214 Thiophene-3-carboxylic acid amide derivatives
04/30/2002US6380199 Treatment of attention deficit hyperactivity disorder
04/30/2002CA2172114C New thiophene compounds, process for preparing the same and pharmaceutical compositions containing them
04/25/2002WO2002033110A2 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM
04/25/2002WO2002032892A1 Process for the preparation of pgd2 antagonist
04/25/2002WO2002032880A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
04/25/2002WO2002032856A2 Insecticidal 1,8-naphthalenedicarboxamides
04/25/2002WO2002032389A1 Method of treating stroke
04/25/2002WO2001097810A3 Use of therapeutic benzamide derivatives
04/25/2002WO2001085683A3 Pyrrolyl-, furanyl- and thienyl-substituted p-aminophenols and colorants containing said compounds
04/25/2002WO2001081333A3 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
04/25/2002US20020049344 New vitamin d derivatives with carbo-or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
04/25/2002US20020049288 Metal-ligand complex precursor composition of an amine containing ligand of given formula and group 3,4, or lanthanide metal compound; polymerizing alpha-olefins, higher comonomer content of C4+ olefins
04/25/2002US20020049234 Inhibitors of factor Xa; for example 3-(4-tert-butylbenzoyl)amino-N-(4-methoxyphenyl)-2-thiophenecarboxamide
04/25/2002US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis
04/25/2002US20020049211 Combination treatment for depression and anxiety
04/25/2002US20020049198 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups
04/25/2002US20020048687 Efficient light emission and excellent heat resistance
04/25/2002CA2426594A1 Production of .alpha.-hydroxy-carboxylic acids using a coupled enzyme system
04/25/2002CA2426097A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
04/25/2002CA2420994A1 Method of treating stroke
04/24/2002EP1198172A1 Use of n-substituted heterocyclylalkylamines as herbicides and novel n-substituted thienylalkylamines
04/24/2002CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4
04/24/2002CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof
04/24/2002CN1346343A 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors
04/24/2002CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
04/24/2002CN1083439C 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators
04/23/2002US6376682 Antidiabetic agents; dietetics
04/23/2002US6376534 Guanidine compound; side effect reduction
04/23/2002US6376533 Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
04/23/2002US6376523 Hypotensive agents; antiinflammatory agents; endogenous vasoconstruction peptide
04/23/2002US6376515 Benzamides and related inhibitors of factor Xa
04/23/2002US6376502 Osteoporosis compounds